COPD-Chronic Obstruction Pulmonary Disease: A Case Study

The purpose of this paper is to discuss an exacerbation of Chronic Obstructive Pulmonary Disease (COPD) and its effect on my patient, Mr. HS, a 78 year old male. In this paper we will look at the various facets in the disease process including its incidence, pathophysiology, presenting complaints, analysis of his clinical presentation, and discuss treatment. We will analyze the effect the disease process has on Mr. HS and will examine his clinical manifestations and laboratory work, as well as provide an outcome analysis. Understanding these various facets will enable one to understand

COPD is an irreversible progressive lung disease that makes it harder for people to breath. According to the Centers of Disease Control and Prevention (2015), COPD is the third leading cause of death in the United States.

Chronic obstructive pulmonary diseases also known as lung cancer is a condition of slow irreversible progressive airway obstruction which gets worse over time. This includes several obstructive diseases of the lungs, including chronic bronchitis, asthma, emphysema, cystic fibrosis and pneumoconiosis. The outcome varies with the consequences with COPD. Approximately 12 million people in the United States have been diagnosed with COPD. According to the Centers for Disease Control and Prevention (CDC), COPD is the fourth leading cause of death in the United States.

The main cause of COPD is smoking, the more smoking the worse it gets, because smoking causes the lungs to inflame which then causes scarring, and by time the scarring leads to permanent changes in the lung which then leads to COPD.

These diseases are mainly caused by the use of tobacco, but also can be triggered from pollution in the air. People who are in contact with second-hand smoke may also experience COPD. Other risk-factors include poorly ventilated homes and fuels that burn during cooking. People 40 years of age or older and have some history of smoking are at increased risk for developing this condition. More than 11 million people are diagnosed with chronic obstruction pulmonary disease.

COPD is the third leading cause of death in the United States and a major cause of morbidity, including visits to a physician, emergency department, or urgent care, as well asand hospitalizations1,2

number one cause of COPD and emphysema shortness of breath and cough are the main

Quitting cigarette smoking: The most effective and important treatment for COPD is to quit cigarette smoking. Patients who continue to smoke will have rapid deterioration in lung function in comparison to those who quit. The aging process itself can cause a very slow decline in lung function. Cigarette smoking can result in a

COPD is the fourth most common cause of death in the United States and rising quickly. It is expected by the year 2020 that it will be number three. Here is a chart breaking

Chronic Obstructive Pulmonary Disease, also known as COPD, is the third leading cause of death in the United States. COPD includes extensive lungs diseases such as emphysema, non-reversible asthma, specific forms of bronchiectasis, and chronic bronchitis. This disease restricts the flow of air in and out of the lungs. Ways in which these limitations may occur include the loss of elasticity in the air sacs and throughout the airways, the destruction of the walls between air sacs, the inflammation or thickening of airway walls, or the overproduction of mucus in airways which can lead to blockage. Throughout this paper I am going to explain the main causes, symptoms, diagnosis, and ways to reduce COPD.

Recognizing the risk factors with COPD are explained as, exposure to tobacco smoke, people who have Asthma who smoke, work-related exposure, age and genetics. Through further details presented in the article, it brings awareness that COPD has 4 different stages, the authors explain the different stages of COPD with the GOLD classification (Global Initiative for Chronic Obstructive Pulmonary Disease). GOLD 1 Mild stage, GOLD 2 Moderate Stage, GOLD 3 Severe Stage and GOLD 4 Very Severe, each stage is determined by the amount of airflow limitations that is produced through the spirometry test and other lung

COPD which is Chronic Obstructive Pulmonary Disease is known as a condition that progressively makes it harder to breathe because the airflow into and out of the lungs is reduced. This usually occurs because the airways and air sacs lose their elastic quality, the walls between the air sacs are destroyed, the walls of the airways become swollen, or if the airways are clogged because they made more mucus than usual. Three main conditions of this disease are emphysema, chronic obstructive bronchitis, and asthma. Most patients who suffer from COPD also suffer from emphysema and chronic bronchitis as to why they are commonly just defined as COPD. The patients who experience one or more of these conditions usually find it even more difficult to

As the number of smokers are rapidly increasing recently, the number of patients with COPD (Chronic Obstructive Pulmonary Disease) is also gradually increasing. It is one of the most common chronic diseases and is considered to be one of the five leading diseases following heart disease, pneumonia, HIV and AIDS worldwide (GOLD, 2004). Smoking is the main cause of COPD. However, long term exposure to chemical fumes and air pollution could also cause COPD. This essay is all about how COPD affects individual, family and society as a whole across their lifespan. Also, it discusses the role of a nurse in caring patients with COPD.

I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,

All over the world, chronic obstructive pulmonary disease (COPD) is a very significant and prevalent cause of morbidity and mortality, and it is increasing with time (Hurd, 2000; Pauwels, 2000; Petty, 2000). Due to the factor of COPD being an underdiagnosed and undertreated disease, the epidemiology (Pauwels, Rabe, 2004) is about 60 to 85 % with mild or moderate COPD remaining undiagnosed (Miravitlles et al., 2009; Hvidsten et al., 2010).